So this is FINRA's response: "Thank you for contacting FINRA’s Office of the Ombudsman. Regarding your question, it would be incorrect to assume that short sales comprise 32% of the total volume on that trading day for IPIX . FINRA publishes the daily short sale volume pursuant to an SEC mandate; however, there are various trading anomalies that result in the reported short sale volume often being exaggerated. Thus, the true total short sales volume may be significantly ( higher or) lower than the volume that is reported. Third parties sometimes ignore this and try to claim the ratio is valid to further their own objectives. "

(higher or as those trading anomalies work both ways) We do know about the T trade anomalies that allow T trades whether short or long not to be included in the reported numbers)

Perhaps Karin will write back to the person who responded to her inquiry and ask for a list of all anomalies that would impact their reporting. I know some market makers have received multi million dollar fines for failing to report short sales to FINRA
https://www.nytimes.com/2016/01/31/business/c...sales.html
Merrill Lynch and Morgan Stanley are also fined:
https://search.myway.com/search/GGmain.jhtml?...amp;st=tab

How many other anomalies are being used by those attacking OTC companies like IPIX?
I look forward to the day we find out exactly who has been attacking IPIX
and they are prosecuted. EROS had 1-31 john does, how many will IPIX have? I think more than 31. Go IPIX!!!